BGI Genomics Co., Ltd. (300676.SZ)
300676.SZ Stock Price Chart
Explore BGI Genomics Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300676.SZ price movements and trends.
300676.SZ Company Profile
Discover essential business fundamentals and corporate details for BGI Genomics Co., Ltd. (300676.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
14 Jul 2017
Employees
3.70K
Website
https://www.bgi.comCEO
Lijian Zhao
Description
BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.
300676.SZ Financial Timeline
Browse a chronological timeline of BGI Genomics Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 25 Apr 2025
EPS came in at -¥1.89 , while revenue for the quarter reached ¥1.04B .
Earnings released on 31 Mar 2025
EPS came in at -¥0.13 , while revenue for the quarter reached ¥671.91M .
Earnings released on 26 Oct 2024
EPS came in at -¥0.35 , while revenue for the quarter reached ¥954.49M .
Earnings released on 23 Aug 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥1.05B .
Dividend declared on 4 Jul 2024
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 4 Jul 2024.
Earnings released on 26 Apr 2024
EPS came in at ¥0.03 , while revenue for the quarter reached ¥817.77M .
Earnings released on 29 Feb 2024
EPS came in at ¥0.05 , while revenue for the quarter reached ¥1.21B .
Earnings released on 27 Oct 2023
EPS came in at ¥0.05 , while revenue for the quarter reached ¥1.07B .
Earnings released on 12 Aug 2023
EPS came in at ¥0.03 , while revenue for the quarter reached ¥1.12B .
Dividend declared on 7 Jun 2023
A dividend of ¥1.00 per share was announced, adjusted to ¥1.00. The dividend was paid on 7 Jun 2023.
Earnings released on 25 Apr 2023
EPS came in at ¥0.13 , while revenue for the quarter reached ¥2.54B .
Earnings released on 31 Mar 2023
EPS came in at ¥0.13 , while revenue for the quarter reached ¥953.75M .
Earnings released on 25 Oct 2022
EPS came in at ¥0.35 , while revenue for the quarter reached ¥1.35B .
Earnings released on 25 Aug 2022
EPS came in at ¥0.68 , while revenue for the quarter reached ¥1.73B .
Dividend declared on 6 Jul 2022
A dividend of ¥0.35 per share was announced, adjusted to ¥0.35. The dividend was paid on 6 Jul 2022.
Earnings released on 22 Apr 2022
EPS came in at ¥0.80 , while revenue for the quarter reached ¥1.43B .
Earnings released on 25 Feb 2022
EPS came in at ¥0.11 , while revenue for the quarter reached ¥1.61B .
Earnings released on 28 Oct 2021
EPS came in at ¥0.80 , while revenue for the quarter reached ¥1.51B .
Earnings released on 27 Aug 2021
EPS came in at ¥1.36 , while revenue for the quarter reached ¥2.08B .
Dividend declared on 7 Jul 2021
A dividend of ¥0.35 per share was announced, adjusted to ¥0.35. The dividend was paid on 7 Jul 2021.
Earnings released on 25 Apr 2021
EPS came in at ¥1.28 , while revenue for the quarter reached ¥1.56B .
Earnings released on 27 Feb 2021
EPS came in at -¥1.54 falling short of the estimated ¥1.68 by -191.67%, while revenue for the quarter reached ¥1.65B .
Earnings released on 28 Oct 2020
EPS came in at ¥2.64 , while revenue for the quarter reached ¥2.64B .
300676.SZ Stock Performance
Access detailed 300676.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.